Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 6/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | NOS2 | P35228 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.38 |
| ▸ | POLB | P06746 | 4/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 3/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31343355 | 0.98 | HPGD (0.43) | HPGDTSHRNPSR1NOS2ALDH1A1 | |
| SCHEMBL9328453 | 0.93 | NOS2 (0.46) | HPGDTSHRNPSR1NOS2ALDH1A1 | |
| SCHEMBL30135339 | 0.93 | NOS2 (0.46) | HPGDTSHRNPSR1NOS2ALDH1A1 | |
| SCHEMBL30135380 | 0.93 | NOS2 (0.46) | HPGDTSHRNPSR1NOS2ALDH1A1 | |
| SCHEMBL27725570 | 0.86 | HPGD (0.44) | HPGDTSHRNPSR1NOS2ALDH1A1 | |
| SCHEMBL8009356 | 0.85 | HPGD (0.34) | HPGDTSHRNPSR1NOS2ALDH1A1 | |
| SCHEMBL22076454 | 0.85 | HPGD (0.41) | HPGDTSHRNPSR1ALDH1A1POLB | |
| SCHEMBL27725568 | 0.84 | HPGD (0.43) | HPGDTSHRNPSR1NOS2ALDH1A1 | |
| SCHEMBL28666355 | 0.83 | HPGD (0.40) | HPGDTSHRNPSR1NOS2ALDH1A1 | |
| SCHEMBL2200874 | 0.83 | HPGD (0.49) | HPGDTSHRNPSR1ALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7465817-B2 | Inositolized phospholipids | CHARITE-UNIVERSITATS MEDIZIN BERLIN (DE) | 2008-12-16 | — | — | US | disclosed |
| EP-1562609-B1 | INOSITOLIZED PHOSPHOLIPIDS | CHARITE UNIVERSITAETSMEDIZIN (DE) | 2006-10-25 | — | — | EP | disclosed |
| US-20060105996-A1 | Inositolized phospholipids | CHARITE-UNIVERSITATS MEDIZIN BERLIN (DE) | 2006-05-18 | — | — | US | disclosed |
| EP-1562609-A1 | INOSITOLIZED PHOSPHOLIPIDS | Charité - Universitätsmedizin Berlin (DE) | 2005-08-17 | — | — | EP | disclosed |
| WO-2004045623-A1 | INOSITOLIZED PHOSPHOLIPIDS | CHARITÉ-UNIVERSITÄTS MEDIZIN BERLIN (DE) | 2004-06-03 | — | — | WO | disclosed |
| EP-1421941-A1 | Phospholipid derivatives having a polyhydroxylated aliphatic carbocycle | Reutter, Werner, Prof. Dr. (DE) | 2004-05-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060105996-A1 | Inositolized phospholipids | PHOSPHO1, SGMS1, CDIPT | HPGD 1416/4885TSHR 2266/4885NPSR1 1431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.